| scholarly article | Q13442814 |
| editorial | Q871232 |
| P50 | author | Csaba P. Kovesdy | Q5191546 |
| Kamyar Kalantar-Zadeh | Q6359924 | ||
| Steven J Jacobsen | Q37384936 | ||
| Miklos Z Molnar | Q38322310 | ||
| Debbie S Gipson | Q42406519 | ||
| Manjula Kurella Tamura | Q42610529 | ||
| Kevin C. Abbott | Q43439652 | ||
| Elani Streja | Q45311701 | ||
| Michael Heung | Q57249855 | ||
| Rajesh Balkrishnan | Q57429732 | ||
| Connie M Rhee | Q88412867 | ||
| Panduranga Rao | Q89866793 | ||
| Richard A Hirth | Q90103928 | ||
| Jennifer Bragg-Gresham | Q90663467 | ||
| Francesca Tentori | Q91650574 | ||
| Brahmajee K Nallamothu | Q91955480 | ||
| Rajiv Saran | Q92638636 | ||
| David T Selewski | Q92742222 | ||
| Friedrich Port | Q95277507 | ||
| Ann M O'Hare | Q102986462 | ||
| John Z Ayanian | Q109937157 | ||
| Joline L T Chen | Q114400135 | ||
| Ronald Pisoni | Q114400190 | ||
| Brett Plattner | Q114400191 | ||
| Vahakn Shahinian | Q114400192 | ||
| Lawrence Y C Agodoa | Q114400193 | ||
| Bruce M. Robinson | Q130388820 | ||
| P2093 | author name string | Yi Li | |
| John J Sim | |||
| Douglas E Schaubel | |||
| Hal Morgenstern | |||
| Paul W Eggers | |||
| Alan B Leichtman | |||
| Peter Song | |||
| Kevin He | |||
| Elizabeth Cope | |||
| Yee Lu | |||
| William Herman | |||
| P433 | issue | 1 Suppl 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United States | Q30 |
| epidemiology | Q133805 | ||
| kidney disease | Q1054718 | ||
| P304 | page(s) | Svii, S1-305 | |
| P577 | publication date | 2015-07-01 | |
| P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
| P1476 | title | US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States | |
| P478 | volume | 66 |
| Q36664020 | A Comparison of Uremic Pruritus in Patients Receiving Peritoneal Dialysis and Hemodialysis |
| Q94673541 | A Systematic Review and Meta-Analysis of Diabetes During Pregnancy and Congenital Genitourinary Abnormalities |
| Q91715564 | A Web-Based Self-Titration Program to Control Blood Pressure in Patients With Primary Hypertension: Randomized Controlled Trial |
| Q45972129 | A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome. |
| Q38992012 | A pharmacy-based medication reconciliation and review program in hemodialysis patients: a prospective study |
| Q52676276 | A plea for more uremic toxin research in children with chronic kidney disease |
| Q34533718 | A wearable artificial kidney for patients with end-stage renal disease |
| Q35982758 | Abatacept Treatment Does Not Preserve Renal Function in the Streptozocin-Induced Model of Diabetic Nephropathy |
| Q39037310 | Advance Directives and End-of-Life Care among Nursing Home Residents Receiving Maintenance Dialysis |
| Q23913086 | Agricultural pesticide exposure and chronic kidney disease: new findings and more questions |
| Q26774178 | An Update on the Use of Animal Models in Diabetic Nephropathy Research |
| Q37510999 | An observational study of health literacy and medication adherence in adult kidney transplant recipients |
| Q47193453 | Analysis of Risk Factors for Kidney Retransplant Outcomes Associated with Common Induction Regimens: A Study of over Twelve-Thousand Cases in the United States. |
| Q91142603 | Anemia is an independent risk factor for cardiovascular and renal events in hypertensive outpatients with well-controlled blood pressure: a subgroup analysis of the ATTEMPT-CVD randomized trial |
| Q39372162 | Anti-TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy. |
| Q38847329 | Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis |
| Q36481807 | Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function |
| Q30352406 | Association Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans. |
| Q98293278 | Association Between Chronic Kidney Disease-Mineral Bone Disease (CKD-MBD) and Cognition in Children: Chronic Kidney Disease in Children (CKiD) Study |
| Q41373333 | Association between ELMO1 gene polymorphisms and diabetic nephropathy in an Iranian population |
| Q89643214 | Association of ELMO1 gene polymorphism and diabetic nephropathy among Egyptian patients with type 2 diabetes mellitus |
| Q40387569 | Association of H. pylori infection with chronic kidney disease among Chinese adults |
| Q51098383 | Association of Lead aVR T-wave Amplitude With Cardiovascular Events or Mortality Among Prevalent Dialysis Patients |
| Q92453187 | Association of cardiovascular structure and function with cerebrovascular changes and cognitive function in older patients with end-stage renal disease |
| Q89942045 | Association of nonalcoholic fatty liver and chronic kidney disease: An analysis of 37,825 cases from health checkup center in Taiwan |
| Q40106923 | Association of pre-operative estimated GFR on post-operative pulmonary complications in laparoscopic surgeries. |
| Q52605517 | Association of short-term blood pressure variability with cardiovascular mortality among incident hemodialysis patients |
| Q40617280 | Averting the Legacy of Kidney Disease - Focus on Childhood |
| Q42750457 | Averting the Legacy of Kidney Disease--Focus on Childhood |
| Q42430577 | Averting the Legacy of Kidney Disease-Focus on Childhood |
| Q54841089 | Averting the Legacy of Kidney Disease: Focus on Childhood. |
| Q41931984 | Averting the legacy of kidney disease - focus on childhood |
| Q36830884 | Averting the legacy of kidney disease - focus on childhood. |
| Q36696530 | Averting the legacy of kidney disease: Focus on childhood |
| Q57771439 | Averting the legacy of kidney disease: focus on childhood |
| Q57771473 | Averting the legacy of kidney disease: focus on childhood |
| Q89402806 | Averting the legacy of kidney disease: focus on childhood |
| Q39019361 | Barriers to live donor kidney transplants in the pediatric population: A single-center experience |
| Q35183903 | Benign hyperfiltration after living kidney donation |
| Q38941321 | Bioavailability, Efficacy and Safety of Generic Immunosuppressive Drugs for Kidney Transplantation: A Systematic Review and Meta-Analysis |
| Q38817264 | Biomaterial-Based Approaches to Address Vein Graft and Hemodialysis Access Failures |
| Q92178276 | Blood Pressure Abnormalities Associated with Gut Microbiota-Derived Short Chain Fatty Acids in Children with Congenital Anomalies of the Kidney and Urinary Tract |
| Q36293118 | Blood pressure and age-related GFR decline in the general population |
| Q47790800 | Blood pressure in hemodialysis: targets? |
| Q38822884 | Both Positive and Negative Fluid Balance May Be Associated With Reduced Long-Term Survival in the Critically Ill. |
| Q38819669 | C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). |
| Q90240701 | Calcium Channel Blocker-Associated Chyloperitoneum in Patients Receiving Peritoneal Dialysis: A Systematic Review |
| Q47293465 | Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial |
| Q55254159 | Chinese herbal medicine Shenzhuo Formula treatment in patients with macroalbuminuria secondary to diabetic kidney disease: study protocol for a randomized controlled trial. |
| Q64073006 | Chinese herbal medicine for diabetic kidney disease: a systematic review and meta-analysis of randomised placebo-controlled trials |
| Q49858961 | Chinese medicine for diabetic kidney disease in China |
| Q36426778 | Chronic Kidney Disease: A Place for Primary Care and Nephrology to Meet |
| Q37119068 | Chronic kidney disease in children. |
| Q35935760 | Circulating S100A12 Levels Are Associated with Progression of Abdominal Aortic Calcification in Hemodialysis Patients |
| Q38733796 | Clinical Trials in Pediatric Autosomal Dominant Polycystic Kidney Disease |
| Q61804334 | Clinical Trials on Diabetic Nephropathy: A Cross-Sectional Analysis |
| Q36108948 | Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients. |
| Q88115576 | Clinical course of rhinosinusitis and efficacy of sinonasal evaluation in kidney transplant recipients: review of 1589 patients |
| Q38921141 | Comparative RNA-Seq transcriptome analyses reveal distinct metabolic pathways in diabetic nerve and kidney disease. |
| Q38754842 | Comparing the Effectiveness of Dynamic Treatment Strategies Using Electronic Health Records: An Application of the Parametric g-Formula to Anemia Management Strategies |
| Q35869088 | Comparison of Plasma and Urine Biomarker Performance in Acute Kidney Injury |
| Q37101485 | Composite Tissue Transplant of Hand or Arm: A Health Technology Assessment |
| Q91989679 | Criteria for classification of protein-energy wasting in dialysis patients: impact on prevalence |
| Q38645455 | Current State and Future Trends to Optimize the Care of African Americans with End-Stage Renal Disease |
| Q38645458 | Current State and Future Trends to Optimize the Care of Chronic Kidney Disease in African Americans |
| Q36712221 | Cystatin C- and Creatinine-Based Estimates of Glomerular Filtration Rate in Dapagliflozin Phase 3 Clinical Trials |
| Q36171329 | DNA hypermethylation in hyperhomocysteinemia contributes to abnormal extracellular matrix metabolism in the kidney |
| Q58557086 | DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS |
| Q91819246 | Demographic, clinical characteristics and cardiovascular disease burden in a Portuguese cohort of older chronic kidney disease patients |
| Q48041579 | Determinant Effects of Average Fasting Plasma Glucose on Mortality in Diabetic End-Stage Renal Disease Patients on Maintenance Hemodialysis |
| Q28385891 | Diabetes, Kidney Disease, and Cardiovascular Outcomes in the Jackson Heart Study |
| Q41983518 | Diabetic Kidney Disease: A Call to Action: Preface |
| Q41993558 | Diabetic Nephropathy: a Tangled Web to Unweave |
| Q37510994 | Diabetic kidney disease patients on hemodialysis: a retrospective survival analysis across different socioeconomic groups |
| Q48648815 | Dialysis Access as an Area of Improvement in Elderly Incident Hemodialysis Patients: Results from a Cohort Study from the International Monitoring Dialysis Outcomes Initiative. |
| Q33799582 | Differential synchrotron X-ray imaging markers based on the renal microvasculature for tubulointerstitial lesions and glomerulopathy |
| Q36267767 | Differentially expressed miR-3680-5p is associated with parathyroid hormone regulation in peritoneal dialysis patients |
| Q37177528 | Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome |
| Q47836044 | Does Kidney Donor Risk Index implementation lead to the transplantation of more and higher-quality donor kidneys? |
| Q36730186 | Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis |
| Q36835081 | Economic Impacts of ABO-Incompatible Live Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients |
| Q38552558 | Editorial: The CXCR4 Ligand/Receptor Family and the DPP4 Protease in High-Risk Cardiovascular Patients |
| Q36520059 | Effect of Advancing Age and Multiple Chronic Conditions on Mortality in Patients with End-Stage Renal Disease after Implantable Cardioverter-Defibrillator Placement |
| Q90715364 | Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes |
| Q38786018 | Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial |
| Q49542557 | Effect of calcitriol on serum hepcidin in individuals with chronic kidney disease: a randomized controlled trial |
| Q51030412 | Effects of exendin-4 on the intrarenal renin-angiotensin system and interstitial fibrosis in unilateral ureteral obstruction mice: Exendin-4 and unilateral ureteral obstruction |
| Q55412646 | Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis. |
| Q46399341 | Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET). |
| Q92060558 | Egr1 Knockdown Combined with an ACE Inhibitor Ameliorates Diabetic Kidney Disease in Mice: Blockade of Compensatory Renin Increase |
| Q37705168 | End-of-life care decisions for haemodialysis patients - 'We only tend to have that discussion with them when they start deteriorating'. |
| Q39140467 | End-stage renal disease and severe aortic stenosis: Does valve replacement improve one-year outcomes? |
| Q51831253 | Engagement in decision-making and patient satisfaction: a qualitative study of older patients' perceptions of dialysis initiation and modality decisions |
| Q91803516 | Epidemiology investigation and analysis of patients with hemodialysis in Sichuan province of China |
| Q36665268 | Epithelial cell fate in the nephron tubule is mediated by the ETS transcription factors etv5a and etv4 during zebrafish kidney development |
| Q90601743 | Evaluation of renal dysfunction using texture analysis based on DWI, BOLD, and susceptibility-weighted imaging |
| Q28067598 | Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update |
| Q39099063 | Experiences of patients undergoing dialysis who are from ethnic and racial minorities |
| Q35758351 | Explore Transplant at Home: a randomized control trial of an educational intervention to increase transplant knowledge for Black and White socioeconomically disadvantaged dialysis patients |
| Q36730482 | Factors Associated With Discontinuation of Home Hemodialysis |
| Q35577405 | Ferric citrate (auryxia) for the treatment of hyperphosphatemia |
| Q38659603 | Fistula First Initiative: Historical Impact on Vascular Access Practice Patterns and Influence on Future Vascular Access Care |
| Q93056841 | Follicle-stimulating hormone promotes renal tubulointerstitial fibrosis in aging women via the AKT/GSK-3β/β-catenin pathway |
| Q38876351 | Functional and Cognitive Impairment, Frailty, and Adverse Health Outcomes in Older Patients Reaching ESRD-A Systematic Review |
| Q52639277 | Functional impairment and risk of mortality in patients on chronic hemodialysis: results of the Lazio Dialysis Registry. |
| Q38478054 | Genetics of diabetic nephropathy: a long road of discovery. |
| Q38409082 | Haemodialysis-induced hypoglycaemia and glycaemic disarrays |
| Q47749734 | Health Disparities in Kidney Transplantation for African Americans |
| Q36304550 | High Serum Level of β2-Microglobulin in Late Posttransplant Period Predicts Subsequent Decline in Kidney Allograft Function: A Preliminary Study |
| Q30842496 | High resolution hemodynamic profiling of murine arteriovenous fistula using magnetic resonance imaging and computational fluid dynamics. |
| Q47156113 | High urinary interleukin-2 in late post-transplant period portends a risk of decline in kidney allograft function: a preliminary study |
| Q40784275 | How Can the Complications of Central Vein Catheters Be Reduced?: From Barrier Protection to Showering: Extraluminal Prophylaxis and Management of Catheter Infections |
| Q36077767 | How Well Does Renal Transplantation Cure Hyperparathyroidism? |
| Q51339455 | Hyperhomocysteinemia increases the risk of chronic kidney disease in a Chinese middle-aged and elderly population-based cohort |
| Q38629320 | Hypertension-attributed nephropathy: what's in a name? |
| Q41726958 | ISN Forefronts Symposium 2015: Nuclear Receptors and Diabetic Nephropathy |
| Q39638026 | Immunologic outcome in elderly kidney transplant recipients: is it time for HLA-DR matching? |
| Q38859653 | Immunosuppression in the elderly renal allograft recipient: a systematic review. |
| Q58576797 | Impact of acute kidney injury in donors on renal graft survival: a systematic review and Meta-Analysis |
| Q33793399 | Impact of poverty and race on pre-end-stage renal disease care among dialysis patients in the United States |
| Q37070031 | Improving Outcomes in Patients Receiving Dialysis: The Peer Kidney Care Initiative |
| Q52587533 | Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference |
| Q36697391 | In time: averting the legacy of kidney disease - focus on childhood |
| Q36566920 | Incidence and Risks of Congenital Anomalies of Kidney and Urinary Tract in Newborns: A Population-Based Case-Control Study in Taiwan |
| Q30238531 | Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies. |
| Q48275977 | Incorporating Scoring Risk Models for Care Planning of the Elderly with Chronic Kidney Disease |
| Q38606468 | Increased Autoreactivity of the Complement-Activating Molecule Mannan-Binding Lectin in a Type 1 Diabetes Model |
| Q42664906 | Increased Risk of Incident Chronic Kidney Disease, Cardiovascular Disease, and Mortality in Patients With Diabetes With Comorbid Depression |
| Q40923940 | Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: A cross-sectional study in China |
| Q93031729 | Individual differences in impulsivity and need for cognition as potential risk or resilience factors of diabetes self-management and glycemic control |
| Q91301250 | Induction Therapy With ATG Compared With Anti-IL2 Basiliximab in Low-Immunologic Risk Kidney Transplant Recipients |
| Q43142418 | Infections Requiring Hospitalization in Patients on Hemodialysis |
| Q52685861 | Influence of pH and phosphate concentration on the phosphate binding capacity of five contemporary binders. An in vitro study |
| Q38633495 | Innate immunity in diabetes and diabetic nephropathy |
| Q37052058 | International Comparisons to Assess Effects of Payment and Regulatory Changes in the United States on Anemia Practice in Patients on Hemodialysis: The Dialysis Outcomes and Practice Patterns Study. |
| Q36482949 | Investigating clinical predictors of arteriovenous fistula functional patency in a European cohort |
| Q43232849 | Is Intravenous Iron Supplementation Safe to Administer to Patients on Hemodialysis with Active Infection--What Do We Know, and What More Do We Need to Know? |
| Q38873515 | JAK inhibition in the treatment of diabetic kidney disease |
| Q52685042 | JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial |
| Q40500215 | Longitudinal assessment of cardiac morphology and function following kidney transplantation |
| Q36373688 | Management of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of Nephropathy |
| Q26752715 | Matrix Metalloproteinases and Subclinical Atherosclerosis in Chronic Kidney Disease: A Systematic Review |
| Q88574835 | Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University |
| Q37721470 | Mechanistic Insight and Management of Diabetic Nephropathy: Recent Progress and Future Perspective. |
| Q91665079 | Metabolic profiling of a chronic kidney disease cohort reveals metabolic phenotype more likely to benefit from a probiotic |
| Q36725972 | Monitoring and Surveillance of Hemodialysis Access |
| Q50934772 | Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal manner |
| Q90000697 | Mortality and potential years of life lost attributable to non-optimal glycaemic control in men and women with diabetes in the United Arab Emirates: a population-based retrospective cohort study |
| Q56927435 | Multiparametric magnetic resonance imaging of experimental chronic kidney disease: A quantitative correlation study with histology |
| Q64902965 | Naringenin Ameliorates Renovascular Hypertensive Renal Damage by Normalizing the Balance of Renin-Angiotensin System Components in Rats. |
| Q39468632 | Nationwide epidemiology and prognosis of dialysis-requiring acute kidney injury (NEP-AKI-D) study: Design and methods |
| Q36678556 | Native Nephrectomy in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease |
| Q58701593 | Net ultrafiltration intensity and mortality in critically ill patients with fluid overload |
| Q38787414 | New Approaches to Arteriovenous Fistula Creation |
| Q38694219 | New molecular insights in diabetic nephropathy |
| Q39096764 | Noteworthy Literature Published in 2016 for Abdominal Organ Transplant Anesthesiologists |
| Q37273724 | Novel Tubular Biomarkers Predict Renal Progression in Type 2 Diabetes Mellitus: A Prospective Cohort Study. |
| Q37522567 | Older candidates for kidney transplantation: Who to refer and what to expect? |
| Q48019115 | PGC-1α Protects from Notch-Induced Kidney Fibrosis Development |
| Q37092343 | PROGRESSION OF CHRONIC KIDNEY DISEASE AFTER ACUTE KIDNEY INJURY. |
| Q36395856 | Parathyroidectomy is underused in patients with tertiary hyperparathyroidism after renal transplantation |
| Q35748917 | Pediatric Chronic Dialysis in Brazil: Epidemiology and Regional Inequalities |
| Q54113688 | Peritoneal Dialysis |
| Q26740472 | Peritoneal Dialysis in Asia |
| Q41037053 | Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients' Survival |
| Q39302938 | Perspectives of Older Kidney Transplant Recipients on Kidney Transplantation |
| Q36040432 | Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis |
| Q42925631 | Podocyte Expression of B7-1/CD80: Is it a Reliable Biomarker for the Treatment of Proteinuric Kidney Diseases with Abatacept? |
| Q51082111 | Polymyxin-B and vancomycin-associated acute kidney injury in critically ill patients. |
| Q90148725 | Post-transplant diabetes mellitus |
| Q28603277 | Postembryonic Nephrogenesis and Persistence of Six2-Expressing Nephron Progenitor Cells in the Reptilian Kidney |
| Q30249723 | Pragmatic Clinical Trials in CKD: Opportunities and Challenges |
| Q47905032 | Pre-ESRD Dementia and Post-ESRD Mortality in a Large Cohort of Incident Dialysis Patients. |
| Q40834381 | Pre-existing and Postoperative Intimal Hyperplasia and Arteriovenous Fistula Outcomes |
| Q39846936 | Predialysis Cardiovascular Disease Medication Adherence and Mortality After Transition to Dialysis |
| Q36262903 | Prediction of clinical outcomes after kidney transplantation from deceased donors with acute kidney injury: a comparison of the KDIGO and AKIN criteria. |
| Q30250300 | Preservation of residual kidney function in hemodialysis patients: reviving an old concept. |
| Q96305529 | Prevalence and Persistence of Uremic Symptoms in Incident Dialysis Patients |
| Q47736998 | Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review |
| Q48195146 | Progression of kidney disease in elderly stage 3 and 4 chronic kidney disease patients |
| Q97644251 | Protective Effect and Possible Mechanisms of Astragaloside IV in Animal Models of Diabetic Nephropathy: A Preclinical Systematic Review and Meta-Analysis |
| Q40073611 | RAS Inhibitor Is Not Associated With Cardiovascular Benefits in Patients Undergoing Hemodialysis in Japan. |
| Q37127480 | Racial Disparities in End-of-Life Communication and Preferences among Chronic Kidney Disease Patients |
| Q40508475 | Racial differences in renal replacement therapy initiation among children with a nonglomerular cause of chronic kidney disease |
| Q41096391 | Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial |
| Q38808265 | Re-evaluation of re-hospitalization and rehabilitation in renal research |
| Q40903669 | Renal Function Profile in White Kidney Donors: The First 4 Decades |
| Q38831049 | Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease |
| Q37545416 | Renal disease pathophysiology and treatment: contributions from the rat. |
| Q40324377 | Renal function affects hippocampal volume and cognition: The role of vascular burden and amyloid deposition |
| Q92134307 | Risk Factors Before Dialysis Predominate as Mortality Predictors in Diabetic Maintenance Dialysis patients |
| Q26764823 | Risk Factors for Development and Progression of Chronic Kidney Disease: A Systematic Review and Exploratory Meta-Analysis |
| Q40638067 | Risk Factors for and Outcomes of Catheter-Associated Peritonitis in Children: The SCOPE Collaborative |
| Q92447303 | Risk factors for catheter-related infections in patients receiving permanent dialysis catheter |
| Q92500126 | Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease: An Analysis of the US Renal Data System |
| Q38817958 | Role of renal urothelium in the development and progression of kidney disease |
| Q38746216 | Safety and cardiovascular effects of mineralocorticoid receptor antagonists for patients receiving hemodialysis: a systematic review and meta-analysis |
| Q40313934 | Satisfaction and Improvements in Peritoneal Dialysis Outcomes Associated with Telehealth |
| Q37239303 | Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment |
| Q26768469 | Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials |
| Q40294037 | Serum uric acid level as an indicator for CKD regression and progression in patients with type 2 diabetes mellitus-a 4.6-year cohort study |
| Q46646555 | Simultaneous measurement of T2 and apparent diffusion coefficient (T2 +ADC) in the heart with motion-compensated spin echo diffusion-weighted imaging |
| Q57796908 | Single-center analysis of infectious complications in older adults during the first year after kidney transplantation |
| Q30250319 | Social Determinants of Racial Disparities in CKD. |
| Q37675571 | Sterile leukocyturia affects urine neutrophil gelatinase-associated lipocalin concentration in type 2 diabetic patients. |
| Q89091602 | Stones: The dark side of stone disease - stones do still kill |
| Q36063933 | Stroke and Risks of Development and Progression of Kidney Diseases and End-Stage Renal Disease: A Nationwide Population-Based Cohort Study |
| Q42551126 | Structural Predictors of Renal Function Decline |
| Q92487319 | Subclinical Cognitive Impairment and Listing for Kidney Transplantation |
| Q39145628 | Sudden Cardiac Death Among Hemodialysis Patients |
| Q36716838 | Surgical Approach to Hemodialysis Access |
| Q46265555 | THE ROLE OF MITOCHONDRIA DERIVED REACTIVE OXYGEN SPECIES IN MICROVASCULAR DYSFUNCTION IN CHRONIC KIDNEY DISEASE. |
| Q64266102 | TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? |
| Q49724077 | Tailored Rabbit Antithymocyte Globulin Induction Dosing for Kidney Transplantation |
| Q45981552 | The Additional Costs and Health Effects of a Patient Having Overweight or Obesity: A Computational Model. |
| Q89522912 | The CKiD study: overview and summary of findings related to kidney disease progression |
| Q36535196 | The Changing Landscape of Renal Inflammation |
| Q38730795 | The Cognitive decline in Older Patients with End stage renal disease (COPE) study - rationale and design. |
| Q42156439 | The Effect of Mycophenolate Mofetil on Early Wound Healing in a Rodent Model |
| Q35914820 | The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney Disease |
| Q91656893 | The Impact of Comorbidity Burden on The Association between Vascular Access Type and Clinical Outcomes among Elderly Patients Undergoing Hemodialysis |
| Q39437042 | The Kidney Transplant Evaluation Process in the Elderly: Reasons for Being Turned down and Opportunities to Improve Cost-Effectiveness in a Single Center |
| Q64235421 | The Level of Serum Albumin Is Associated with Renal Prognosis in Patients with Diabetic Nephropathy |
| Q57784815 | The National Kidney Foundation of Illinois KidneyMobile: a mobile resource for community based screenings of chronic kidney disease and its risk factors |
| Q88208153 | The Relationship of Residual Renal Function with Cardiovascular Morbidity in Hemodialysis Patients and the Potential Role of Monocyte Chemoattractant Protein-1 |
| Q89539962 | The Role of Endothelin and Endothelin Antagonists in Chronic Kidney Disease |
| Q42397515 | The Surging Tide of Diabetes: Implications for Nephrology |
| Q58792844 | The Use of Aspirin to Reduce the Risk of Thrombotic Events in Patients With End-Stage Renal Disease: Protocol for a Randomized Controlled Trial |
| Q39710363 | The association between midlife cardiorespiratory fitness and later life chronic kidney disease: The Cooper Center Longitudinal Study. |
| Q36220773 | The clinical and economic burden of pneumonia in patients enrolled in Medicare receiving dialysis: a retrospective, observational cohort study |
| Q36827355 | The dose-response effect of insulin sensitivity on albuminuria in children according to diabetes type |
| Q37663914 | The economic considerations of patients and caregivers in choice of dialysis modality |
| Q92053550 | The effects of vascular access types on the survival and quality of life and depression in the incident hemodialysis patients |
| Q36482865 | The global nephrology workforce: emerging threats and potential solutions! |
| Q39191137 | The tbx2a/b transcription factors direct pronephros segmentation and corpuscle of Stannius formation in zebrafish |
| Q38605099 | Therapies on the Horizon for Diabetic Kidney Disease. |
| Q42423016 | Timing of Dialysis Initiation-Do Health Care Setting or Provider Incentives Matter? |
| Q36592770 | Timing of Initiation of Maintenance Dialysis: A Qualitative Analysis of the Electronic Medical Records of a National Cohort of Patients From the Department of Veterans Affairs |
| Q38959946 | Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney disease |
| Q35026517 | Translational nephrology: what translational research is and a bird's-eye view on translational research in nephrology |
| Q39332082 | Trends in Receipt of Intensive Procedures at the End of Life Among Patients Treated With Maintenance Dialysis |
| Q38845672 | Trends in management of the small renal mass in renal transplant recipient candidates: A multi-institutional survey analysis |
| Q36297539 | Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy |
| Q30358290 | Ultrasound Elastography: Review of Techniques and Clinical Applications. |
| Q64072230 | Untargeted metabolomics reveals N, N, N-trimethyl-L-alanyl-L-proline betaine (TMAP) as a novel biomarker of kidney function |
| Q40690963 | Urinary Mitochondrial DNA Copy Number Identifies Chronic Renal Injury in Hypertensive Patients |
| Q58706935 | Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease |
| Q38676567 | Use of Kidneys with Small Renal Tumors for Transplantation |
| Q55019846 | Weight loss has an additive effect on the proteinuria reduction of angiotensin II receptor blockers in hypertensive patients with chronic kidney disease. |
| Q47632786 | World Kidney Day 2016 Averting The Legacy of Kidney Disease-Focus On Childhood |
| Q57771463 | World Kidney Day 2016: Averting the legacy of kidney disease—focus on childhood |
| Q58760376 | lectin alleviates diabetic nephropathy by inhibiting the LOX1/NF-κB/caspase-9 signaling pathway |
Search more.